Oric Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Oric Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2024.
  • Oric Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 70.5M shares, a 22.9% increase year-over-year.
  • Oric Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 51.5M shares, a 29.7% increase from 2022.
  • Oric Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 39.7M shares, a 4.48% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 70.5M +13.1M +22.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 70.3M +24.7M +54.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 67.3M +22.3M +49.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 51.5M +11.8M +29.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 57.4M +17.8M +45% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 45.7M +6.17M +15.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 45.1M +5.66M +14.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 39.7M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 39.6M +568K +1.46% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 39.5M +2.78M +7.57% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 39.4M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q3 2021 39M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 36.7M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.